TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35618562

Group type: COMPARATOR
Intervention: Iodixanol 270 mg I/ml
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 2
Study: 33397174

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral TAP block
Number of subjects: 60

Group type: COMPARATOR
Intervention: No TAP block (Control Group B)
Number of subjects: 60
Study: 36484969

Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 804

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 804
Study: 33652438

Group type: EXPERIMENTAL
Intervention: Alternative Flicker Glass (AFG) - worn for 1 hour a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Patching - worn for 2 hours a day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alternative Flicker Glass (AFG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Patching
Number of subjects: 40
Study: 33385191

Group type: EXPERIMENTAL
Intervention: Lumbosacral orthosis (LSO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Abdominal drawing-in maneuver (ADIM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Without lumbar stabilization
Number of subjects: 20
Study: 32980586

Group type: EXPERIMENTAL
Intervention: Performance-oriented task
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Rejection-oriented task
Number of subjects: 114
Study: 35417485

Group type: EXPERIMENTAL
Intervention: Standard-of-care PrEP counseling with two-way SMS adherence support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard-of-care PrEP counseling with WhatsApp group adherence support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quarterly drug-level feedback counseling (for non-responders)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monthly issue-focused counseling (for non-responders)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary outcome: PrEP adherence at nine months (TFV-DP ≥700 fmol/punch)
Number of subjects: 0
Study: 33199423

Group type: EXPERIMENTAL
Intervention: Micronutrient supplement containing 0.8 mg of folic acid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Micronutrient supplement without folic acid
Number of subjects: 100
Study: 33958863

Group type: EXPERIMENTAL
Intervention: Easyhaler inhaler (placebo powder)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: HandiHaler inhaler (placebo capsules)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Easyhaler and HandiHaler inhalers
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: In-Check Dial device
Number of subjects: 200
Study: 32928276

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Sham electro-acupuncture (sham EA)
Number of subjects: 252
Study: 34411291

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser-assisted periodontal therapy (3 W, 100 μs, 20 Hz; 4 W, 600 μs, 20 Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (laser off)
Number of subjects: 20
Study: 32576297

Group type: EXPERIMENTAL
Intervention: Whole Egg + Resistance Training (WER)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Egg White + Resistance Training (EWR)
Number of subjects: 30
Study: 36314174

Group type: EXPERIMENTAL
Intervention: Intranasal GM‐CSF administration
Number of subjects: 92
Study: 32343634

Group type: EXPERIMENTAL
Intervention: Multicomponent nonpharmacological delirium prevention intervention
Number of subjects: 65

Group type: COMPARATOR
Intervention: Waitlist sites (control)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Intervention sites
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Waitlist sites
Number of subjects: 65
Study: 35871638

Group type: EXPERIMENTAL
Intervention: Low-dose endotoxin (0.8 ng/kg of body weight)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 114
Study: 34459493

Group type: EXPERIMENTAL
Intervention: Preoperative pain neuroscience education (PNE) plus knee joint mobilization
Number of subjects: 44

Group type: COMPARATOR
Intervention: Biomedical education plus knee joint mobilization
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Preoperative pain neuroscience education (PNE)
Number of subjects: 44
Study: 32155254

Group type: EXPERIMENTAL
Intervention: Group antenatal care (G-ANC)
Number of subjects: 330
Study: 35012455

Group type: EXPERIMENTAL
Intervention: GRAde long-read sequencing approach
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PCR products indicating a chimeric gene
Number of subjects: 36
Study: 34949967

Group type: EXPERIMENTAL
Intervention: Lung rehabilitation training using the BioMaster virtual scene interactive rehabilitation training system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine lung rehabilitation training
Number of subjects: 60
Study: 36317757

Group type: EXPERIMENTAL
Intervention: Test drug (biosimilar)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Reference drug (trastuzumab)
Number of subjects: 70
Study: 33001851

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention on video-assisted teaching regarding nature of the disease condition including diet, medication, hand and leg exercises, home care management for 30 mins.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care (Control group).
Number of subjects: 0
Study: 36261616

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional
Number of subjects: 40
Study: 34549535

Group type: EXPERIMENTAL
Intervention: Weight gain prevention intervention
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 599
Study: 34318949

Group type: EXPERIMENTAL
Intervention: Sufficient physical space
Number of subjects: 1850

Group type: EXPERIMENTAL
Intervention: Sufficient variety of stimulation
Number of subjects: 1850

Group type: EXPERIMENTAL
Intervention: Fine-motor toys
Number of subjects: 1850

Group type: EXPERIMENTAL
Intervention: Gross motor toys
Number of subjects: 1850
Study: 34880026

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) - seven sessions focused on expectancy management, cognitions regarding pain, and emotional and behavioural impact of pain
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 100
Study: 34716684

Group type: EXPERIMENTAL
Intervention: Real-time feedback device
Number of subjects: 900

Group type: COMPARATOR
Intervention: Standard manual chest compression
Number of subjects: 900
Study: 36076192

Group type: EXPERIMENTAL
Intervention: Prompt Mental Health Care (PMHC)
Number of subjects: 459
Study: 34611418

Group type: EXPERIMENTAL
Intervention: Super bioavailable itraconazole (SBITZ) capsules
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional itraconazole (CITZ) capsules
Number of subjects: 70
Study: 32512782

Group type: EXPERIMENTAL
Intervention: Longvida© (400 mg daily containing 80 mg curcumin)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34016033

Group type: EXPERIMENTAL
Intervention: Transnational home-based elder care system
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Policies for formalization and legalization of care services
Number of subjects: 28
Study: 32586393

Group type: EXPERIMENTAL
Intervention: Molecularly driven treatment selection based on biomarker profile
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current clinical practice (control)
Number of subjects: 0
Study: 35691326

Group type: EXPERIMENTAL
Intervention: Short treatment group (500 mg intravenous imipenem-cilastatin four times a day for 72 hours)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Extended treatment group (1000 mg intravenous meropenem three times a day for ≥9 days)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Short treatment group
Number of subjects: 281

Group type: COMPARATOR
Intervention: Extended treatment group
Number of subjects: 281
Study: 34512522

Group type: EXPERIMENTAL
Intervention: Routine treatment plus acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine treatment plus sham acupuncture
Number of subjects: 120
Study: 34351555

Group type: EXPERIMENTAL
Intervention: S-1 plus docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: S-1 alone
Number of subjects: 0
Study: 34287979

Group type: EXPERIMENTAL
Intervention: Glepaglutide 10 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Glepaglutide 0.1 mg and 1 mg
Number of subjects: 18
Study: 34655522

Group type: EXPERIMENTAL
Intervention: MVC-COV1901
Number of subjects: 3854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3854
Study: 34675112

Group type: EXPERIMENTAL
Intervention: I-PET after four cycles of R(R)-CHOP14
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: ΔSUVmax
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Deauville score (DS)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: aaIPI and ΔSUVmax
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Low/low-intermediate aaIPI combined with ΔSUVmax >70%
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: High-intermediate/high aaIPI combined with ΔSUVmax=70%
Number of subjects: 513
Study: 32011094

Group type: EXPERIMENTAL
Intervention: Group VCD (Celtra Duo zirconia‐reinforced glass ceramics)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group VK (KATANA monolithic zirconia)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group HCD (Celtra Duo zirconia‐reinforced glass ceramics)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group HK (KATANA monolithic zirconia)
Number of subjects: 40
Study: 35695389

Group type: EXPERIMENTAL
Intervention: Hoffman's exercise
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (without Hoffman's exercise)
Number of subjects: 55
Study: 33140267

Group type: EXPERIMENTAL
Intervention: Diode laser (810 nm, 1.0 W, CW, irradiation time 20 s for 3 applications) once daily for 3 days
Number of subjects: 56

Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% three times a day until the lesion was healed
Number of subjects: 56
Study: 33007041

Group type: EXPERIMENTAL
Intervention: Ugandan birthweight standard
Number of subjects: 926

Group type: COMPARATOR
Intervention: WHO curve
Number of subjects: 926

Group type: COMPARATOR
Intervention: Malawi curve
Number of subjects: 926

Group type: COMPARATOR
Intervention: INTERGROWTH-21st curve
Number of subjects: 926
Study: 35525255

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (men)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Low-fat diet (men)
Number of subjects: 1002
Study: 32969330

Group type: EXPERIMENTAL
Intervention: Samata programme
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 31
Study: 33211314

Group type: EXPERIMENTAL
Intervention: Palbociclib plus letrozole
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 421
Study: 34052346

Group type: EXPERIMENTAL
Intervention: Resistance and aerobic exercise training for 3 months upon ADT onset (N = 70)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Usual care for 3 months upon ADT onset (N = 61)
Number of subjects: 131
Study: 32095845

Group type: EXPERIMENTAL
Intervention: Surveillance ultrasonography
Number of subjects: 2065
Study: 36121127

Group type: EXPERIMENTAL
Intervention: MyHealthyWeight (MHW) app and a wearable activity tracker (WAT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard antenatal treatments with no mHealth‐based elements (Control)
Number of subjects: 92
Study: 33422365

Group type: EXPERIMENTAL
Intervention: Intensive alcohol and smoking cessation intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Successful quitting of alcohol and smoking
Number of subjects: 94
Study: 33227441

Group type: EXPERIMENTAL
Intervention: 42.6 Gy in 10 fractions (Hypofractionated RT)
Number of subjects: 32
Study: 35429906

Group type: EXPERIMENTAL
Intervention: Breathing training during the pre-operative visit
Number of subjects: 170

Group type: COMPARATOR
Intervention: Pre-operative visit only (Control group)
Number of subjects: 170
Study: 33325562

Group type: EXPERIMENTAL
Intervention: Acarbose (1 x 50 mg) with concomitant administration of sucrose
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Acarbose (1 x 50 mg, 2 x 50 mg, 3 x 50 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Acarbose (2 x 50 mg)
Number of subjects: 36
Study: 32943031

Group type: EXPERIMENTAL
Intervention: e‐DA (online patient decision-aid)
Number of subjects: 352
Study: 35631202

Group type: EXPERIMENTAL
Intervention: SAIbi educa nutrition app
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 33913637

Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 3476

Group type: COMPARATOR
Intervention: Darbepoetin alfa (Control)
Number of subjects: 3476
Study: 35750456

Group type: EXPERIMENTAL
Intervention: Contralateral acupuncture (CAT)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Ipsilateral acupuncture (IAT)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 243
Study: 35396595

Group type: COMPARATOR
Intervention: Pump infiltration
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Manual infiltration
Number of subjects: 14
Study: 33507775

Group type: EXPERIMENTAL
Intervention: Oxytocin synchrony between patients and therapists
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Therapist-patient OT synchrony
Number of subjects: 37
Study: 34775875

Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine health management (Control)
Number of subjects: 94
Study: 34062261

Group type: EXPERIMENTAL
Intervention: Low-Intensity Continuous Training (LICT)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training plus Interval Training (MICT+IT)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: MICT+IT
Number of subjects: 142
Study: 32050208

Group type: EXPERIMENTAL
Intervention: Pentacam HR 25-picture mode
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pentacam HR 50-picture mode
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pentacam HR cornea fine mode
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pentacam HR 25-picture mode (second observer)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pentacam HR 25-picture mode (posterior elevation Zernike term Z1)
Number of subjects: 100
Study: 35232426

Group type: EXPERIMENTAL
Intervention: Later cord clamping (LCC) (≥ 30 s after birth)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC) (≤ 15 s after birth)
Number of subjects: 368
Study: 34988583

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) - 3 sessions per week, parent-led, infant-directed singing supported by a music therapist; mean of 10 sessions (SD 5.95), with 83% receiving at least 6 sessions.
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard Care (C) - control group receiving usual care without music therapy.
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) - 3 sessions per week, parent-led, infant-directed singing supported by a music therapist.
Number of subjects: 213
Study: 34554243

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 or 300 mg every 4 or 8 weeks
Number of subjects: 74
Study: 32264919

Group type: EXPERIMENTAL
Intervention: Upfront radical surgery with total mesorectal excision (TME) followed by adjuvant FOLFOX chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative chemoradiotherapy (PCRT) followed by TME and adjuvant chemotherapy
Number of subjects: 0
Study: 32344098

Group type: EXPERIMENTAL
Intervention: HIIT at alternating 80% (3min) and 40% (3min) VO2peak
Number of subjects: 23

Group type: COMPARATOR
Intervention: MICT at 60% of peak oxygen consumption (VO2peak)
Number of subjects: 23
Study: 35438337

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered curriculum for cancer survivors with ostomies
Number of subjects: 15
Study: 32677911

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 20060

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20060

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 20060
Study: 35165274

Group type: EXPERIMENTAL
Intervention: sintilimab
Number of subjects: 0

Group type: COMPARATOR
Intervention: chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: NLR ≥ 3
Number of subjects: 0
Study: 33796907

Group type: COMPARATOR
Intervention: IV nicotine (0.0125, 0.025, 0.05, 0.1, or 0.2 mg nicotine/70 kg bodyweight)
Number of subjects: 34

Group type: COMPARATOR
Intervention: IV nicotine (0.2 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 34
Study: 36356279

Group type: EXPERIMENTAL
Intervention: Geriatric Assessment (GA) intervention
Number of subjects: 706

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 706
Study: 33487304

Group type: EXPERIMENTAL
Intervention: Black coffee (8 oz)
Number of subjects: 10
Study: 32944971

Group type: EXPERIMENTAL
Intervention: Group acceptance and commitment therapy for Psychosis (G‐ACTp) delivered by trained staff and service-user experts, comprising four sessions over weeks 1-4 and two booster sessions at weeks 10 and 12.
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (delayed G‐ACTp after 12 weeks).
Number of subjects: 191
Study: 36116025

Group type: EXPERIMENTAL
Intervention: Slide Compression Anatomic Plates of the Femoral Neck (SCAP-FN)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dynamic Hip Screw systems (DHS) + Derotational Screw (DS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cannulated Compression Screws (CCS)
Number of subjects: 45
Study: 33146769

Group type: EXPERIMENTAL
Intervention: TissuGlu® without drainage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard wound care with drain insertion
Number of subjects: 0
Study: 33756298

Group type: EXPERIMENTAL
Intervention: Summer season body image
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Winter season body image
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Overall seasonal body image
Number of subjects: 823
Study: 34388179

Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham sessions
Number of subjects: 43
Study: 33847780

Group type: EXPERIMENTAL
Intervention: Mono-J insertion for 6 hours after ureterorenoscopy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Double-J insertion for 3-5 days after ureterorenoscopy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Tubeless procedure
Number of subjects: 108
Study: 34711445

Group type: EXPERIMENTAL
Intervention: Portioning information strategy (pauses during information provision)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-portioning pauses
Number of subjects: 34
Study: 34965950

Group type: EXPERIMENTAL
Intervention: 2 weeks of aromatase inhibitors (AI)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Longer-term neoadjuvant AI (NeoAI)
Number of subjects: 264

Group type: COMPARATOR
Intervention: No-treatment (Control)
Number of subjects: 264
Study: 32471908

Group type: EXPERIMENTAL
Intervention: Lixisenatide (20 μg subcutaneously daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35841410

Group type: EXPERIMENTAL
Intervention: RAM + ERL (ramucirumab 10 mg/kg every 2 weeks with erlotinib 150 mg/day)
Number of subjects: 441

Group type: COMPARATOR
Intervention: PBO + ERL (placebo with erlotinib 150 mg/day)
Number of subjects: 441
Study: 33763789

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus carboplatin (group A1)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Eribulin plus carboplatin (group A2)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Eribulin plus cyclophosphamide (group B1)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Eribulin plus capecitabine (group B2)
Number of subjects: 99
Study: 32696226

Group type: EXPERIMENTAL
Intervention: Continuous ESP block with ropivacaine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Continuous ESP block with 0.9% saline (saline group)
Number of subjects: 82
Study: 36127862

Group type: EXPERIMENTAL
Intervention: Tele-education programme based on the health belief model (8 sessions over 15 days)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (no tele-education)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Tele-education programme based on the health belief model
Number of subjects: 149
Study: 32926893

Group type: EXPERIMENTAL
Intervention: Multiplex quantitative real‐time polymerase chain reaction (mqPCR) assay for PCV2 genotypes
Number of subjects: 0
Study: 35378137

Group type: EXPERIMENTAL
Intervention: Archetype 1 (normal VF pattern)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Global score of AT change
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Baseline AT2 (mild diffuse VF loss pattern) weight of 44% or more
Number of subjects: 165

Group type: COMPARATOR
Intervention: Acetazolamide treatment
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Residual VF loss patterns
Number of subjects: 165
Study: 33429768

Group type: EXPERIMENTAL
Intervention: Rifaximin 1200 mg/d for 10 days, 20 days free of treatment, repeated for 3 courses over 3 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (antispasmodics as needed, observed for 3 months)
Number of subjects: 86
Study: 32470230

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (30-70 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33970692

Group type: EXPERIMENTAL
Intervention: Early complex decongestive therapy (CDT) started within 2 weeks after surgery for 30 minutes a day, for 2 weeks (5 days per week)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Early complex decongestive therapy (CDT)
Number of subjects: 31
Study: 33867262

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 35298858

Group type: EXPERIMENTAL
Intervention: Moisturizer containing pseudo-ceramide and eucalyptus extract
Number of subjects: 19

Group type: COMPARATOR
Intervention: Moisturizer without pseudo-ceramide and eucalyptus extract
Number of subjects: 19